Tyra Bioscience's total assets for Q2 2025 were $321.50M, a decrease of -6.40% from the previous quarter. TYRA total liabilities were $19.35M for the fiscal quarter, a -2.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.